417 related articles for article (PubMed ID: 10373290)
1. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
2. p53 expression and apoptosis in melanomas of dogs and cats.
Roels S; Tilmant K; Ducatelle R
Res Vet Sci; 2001 Feb; 70(1):19-25. PubMed ID: 11170847
[TBL] [Abstract][Full Text] [Related]
3. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
5. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
[TBL] [Abstract][Full Text] [Related]
6. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
[TBL] [Abstract][Full Text] [Related]
7. Feline non-ocular melanoma: a retrospective study of 23 cases (1991-1999).
Luna LD; Higginbotham ML; Henry CJ; Turnquist SE; Moore AS; Graham JC
J Feline Med Surg; 2000 Dec; 2(4):173-81. PubMed ID: 11716616
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
[TBL] [Abstract][Full Text] [Related]
10. Proliferation, DNA ploidy, p53 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours.
Roels S; Tilmant K; Van Daele A; Van Marck E; Ducatelle R
J Vet Med A Physiol Pathol Clin Med; 2000 Sep; 47(7):439-48. PubMed ID: 11076465
[TBL] [Abstract][Full Text] [Related]
11. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia.
Spangler WL; Kass PH
Vet Pathol; 2006 Mar; 43(2):136-49. PubMed ID: 16537931
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
14. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
[TBL] [Abstract][Full Text] [Related]
15. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
16. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
20. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]